Mairs & Power Inc Reata Pharmaceuticals Inc Transaction History

Mairs & Power Inc

  • $10.5 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$25.61 - $110.96 $51,220 - $221,920
-2,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$78.27 - $151.29 $156,540 - $302,580
2,000 New
2,000 $283,000
Q1 2021

May 14, 2021
SELL
$94.25 - $132.81 $188,500 - $265,620
-2,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$102.03 - $184.62 $204,060 - $369,240
2,000 New
2,000 $247,000
Q3 2020

Nov 16, 2020
SELL
$93.53 - $163.34 $187,060 - $326,680
-2,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$74.57 - $217.92 $149,140 - $435,840
2,000 New
2,000 $409,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email